Indeed, 50% of MOC2-CIITA injected mice rejected the tumor (Supplementary Figure S4B) and the remaining 50% showed a significant delay in tumor growth compared to MOC2-mock tumor-bearing mice (Supplementary Figure S4C). The gene discussed is CIITA; the disease is neoplasm.